Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis – Bone
Reexamination Certificate
2000-05-26
2008-11-04
Isabella, David J (Department: 3774)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
Bone
C623S023580, C514S054000, C514S055000, C530S400000, C536S053000
Reexamination Certificate
active
07445641
ABSTRACT:
The present invention relates to biomaterials modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. This modification may be by covalent conjugation, copolymerization, or admixture of the non-proteinaceous catalysts with the biomaterial. The resulting modified biomaterials exhibit a marked decrease in inflammatory response and subsequent degradation when placed in contact with vertebrate biological systems.
REFERENCES:
patent: 4514589 (1985-04-01), Aldinger et al.
patent: 4718908 (1988-01-01), Wigginton et al.
patent: 4775426 (1988-10-01), Murley et al.
patent: 4863964 (1989-09-01), Hedlund et al.
patent: 5013323 (1991-05-01), Kobayashi et al.
patent: 5227405 (1993-07-01), Fridovich et al.
patent: 5386012 (1995-01-01), Strid
patent: 5397362 (1995-03-01), Noda
patent: 5403834 (1995-04-01), Malfroy-Camine et al.
patent: 5525621 (1996-06-01), Burt et al.
patent: 5610293 (1997-03-01), Riley et al.
patent: 5626861 (1997-05-01), Laurencin et al.
patent: 5626863 (1997-05-01), Hubbell et al.
patent: 5637578 (1997-06-01), Riley et al.
patent: 5665428 (1997-09-01), Cha et al.
patent: 5696109 (1997-12-01), Malfroy-Camine et al.
patent: 5711763 (1998-01-01), Nonami et al.
patent: 5749839 (1998-05-01), Kovacs
patent: 5766618 (1998-06-01), Laurencin et al.
patent: 5800456 (1998-09-01), Maeda et al.
patent: 5817303 (1998-10-01), Stedronski et al.
patent: 5824047 (1998-10-01), Moreland
patent: 5827880 (1998-10-01), Malfroy-Camine et al.
patent: 5830539 (1998-11-01), Yan et al.
patent: 5834509 (1998-11-01), Malfroy-Camine et al.
patent: 5836313 (1998-11-01), Perez et al.
patent: 5837752 (1998-11-01), Shastri et al.
patent: 5840319 (1998-11-01), Alakhov et al.
patent: 5851227 (1998-12-01), Spehr
patent: 5861032 (1999-01-01), Subramaniam
patent: 5869103 (1999-02-01), Yeh et al.
patent: 5871535 (1999-02-01), Wolff et al.
patent: 5873904 (1999-02-01), Ragheb et al.
patent: 5874421 (1999-02-01), Riley et al.
patent: 5876433 (1999-03-01), Lunn
patent: 5876452 (1999-03-01), Athanasiou et al.
patent: 5877263 (1999-03-01), Patnaik et al.
patent: 5879359 (1999-03-01), Dorigatti et al.
patent: 5879697 (1999-03-01), Ding et al.
patent: 5885609 (1999-03-01), Amiji
patent: 5889130 (1999-03-01), Worley et al.
patent: 5891862 (1999-04-01), Mandeville, III et al.
patent: 6084093 (2000-07-01), Riley et al.
patent: 6323218 (2001-11-01), Bush et al.
patent: 6506411 (2003-01-01), Hunter et al.
patent: 6774278 (2004-08-01), Ragheb et al.
patent: 6939569 (2005-09-01), Green et al.
patent: 2004/0110722 (2004-06-01), Omberg et al.
patent: 2004/0116332 (2004-06-01), Omberg et al.
patent: 2004/0131550 (2004-07-01), Neumann et al.
patent: 108806 (1994-06-01), None
patent: 0 524 161 (1993-01-01), None
patent: 0 524 161 (1993-01-01), None
patent: 0 679155 (1997-08-01), None
patent: 0 598753 (1998-03-01), None
patent: 0747069 (2002-09-01), None
patent: 2231078 (1990-09-01), None
patent: WO 93/11800 (1993-06-01), None
patent: WO 93/14093 (1993-07-01), None
patent: WO 95/28968 (1995-11-01), None
patent: WO 96/39396 (1996-12-01), None
patent: WO 96/39409 (1996-12-01), None
patent: WO 96/40658 (1996-12-01), None
patent: WO 97/33588 (1997-09-01), None
patent: WO 97/33877 (1997-09-01), None
patent: WO 98/58636 (1998-12-01), None
Alexander, et al., “Manganese(II) Complexes of a Macrocyclic Ligand,” 1970, (Inorganic Nuclear Chemistry Letters, vol. 6), pp. 445-448.
Richman, et al., “Nitrogen Analogs of Crown Ethers,” Apr. 3, 1974, (Journal of the American Chemical Society, vol. 96), p. 7.
Brady, et al., “Practical Synthesis of Cyclic Peptides, with an Example of Dependence of Cyclization Yield Upon Linear Sequence,” 1979, (Journal of Organic Chemistry, vol. 44, No. 18), pp. 3101-3105.
Kimura, et al., “Superoxide Dismutase Activity of Macrocylic Polyamine Complexes,” 1981 (Biochimica et Biophysica Acta, vol. 678), pp. 172-179.
Gryglewski, et al., “Superoxide Anion is Involved in the Breakdown of Endothelium-Derived Vascular Relaxing Factor,” Apr. 1986, (Nature, vol. 320), pp. 454-456.
Bannister, et al., “Aspects of the Structure, Function, and Applications of Superoxide Dismutase,” 1987, (CRC Critical Reviews in Biochemistry, vol. 22, Issue 2), pp. 111-180.
Newton, et al., “Synthesis and Characterization of the Mn(II) Complex of [15]aneN5,” 1988, (J. Coord. Chem, vol. 19), pp. 265-277.
Cremer, et al., “Oxygen Free Radical Scavengers to Prevent Pulmonary Reperfusion Injury After Heart-Lung Transplantation,” Jul./Aug. 1989, (The Journal of Heart Transplantation, vol. 8, No. 4), pp. 330-336.
Bradshaw, et al., “A Simple Crab-Like Cyclization Procedure to Prepare Polyaza-Crowns and Cyclams with One or Two Unsubstituted Macroring Nitrogen Atoms or with a Hydroxy Group,” Sep./Oct. 1989, (J. Heterocyclic Chem., vol. 26), pp. 1431-1435.
Lindoy, L.F., “The Chemistry of Macrocyclic Ligand Complexes,” 1989 (The Press Syndicate of the University of Cambridge), pp. 16, 40 and 42.
Ferrari et al., “Superoxide Dismutase: Possible Therapeutic Use in Cardiovascular Disease,” 1989, (Pharmalogical Research, vol. 21, Supplement 2), pp. 57-65.
Krakowiak, et al., “Preparation of Triaza-, Tetraaza- and Peraza-Crown Compounds Containing Aminoalkyl Side Groups of Unsubstituted Ring Nitrogen Atoms,” 1990, (J. Org, Chem., vol. 55, No. 10), pp. 3364-3368.
Riley, et al., “Stooped-Flow Kinetic Analysis for Monitoring Superoxide Decay in Aqueous Systems,” 1991, (Analytical Biochemistry, vol. 196), pp. 344-349.
Weiss, et al., “Catalytic Efficacies of Agents that Dismutate Superoxide,” 1991, (J. Cell. Biochem., Supplement 15C), p. 216.
Aston, et al., “Asymmetric Synthesis of Highly Functionalized Polyazamacrocycles via Reduction of Cyclic Peptide Precursors,” 1994, (Tetrahedron Letters, vol. 35, No. 22), pp. 3687-3690.
Lin, et al., “Use of Superoxide Dismutase (SOD) in Patients with Temporomandibular Joint Dysfunction—a Preliminary Study,” 1994, (International Journal of Oral Maxillofacial Surgery, vol. 23), pp. 428-429.
Hardy, et al., “Superoxide Dismutase Mimetics Inhibit Neutrophil-Mediated Human Aortic Endothelial Cell Injury in Vitro*,” 1994, (The Journal of Biological Chemistry, vol. 269, No. 28), pp. 18535-18540.
Bulkley, G.B., “Reactive Oxygen Metabolites and Reperfusion Injury: Aberrant Triggering of Reticuloendothelial Function,” Oct. 1994, (The Lancet, vol. 344), pp. 934-936.
Babior, B.M., “Superoxide: a Two-Edged Sword,” 1997, (Brazilian Journal of Medical and Biological Research, vol. 30), pp. 141-155.
Weiss et al., “Manganese-Based Superoxide Dismutase Mimics: Design, Discovery and Pharmacologic Efficacies”, In The Oxygen Paradox, 1995 (CLEUP University Press, Padova, Italy), pp. 641-651.
Weiss et al., “Maganese-Based Superoxide Dismutase Mimetics Inhibit Neutrophil Infiltration In Vivo”, 1996, (J. Biol., Chem., vol. 271). pp. 26149-26156.
Kasten et al., “Potentiation of Nitric Oxide Mediated Vascular Relaxation by SC-52608, A Superoxide Dismutase Mimic”, 1995 (Proc. Soc. Exp. Biol. Med., vol. 208), pp. 170-177.
Hardy et al., “Superoxide Dismutase Mimetics Inhibit Neutrophil-Mediated Human Aortic Endothelial Cell Injury In Vitro”, 1997, (J. Biol. Chem., vol. 269), pp. 18535-18540.
Kilgore et al., “Protective Effects of the SOD-Mimetic SC-52608 Against Ischemia/Reperfusion Damage in the Rabbit Isolated Heart”, 1994, (J. Mol. Cell. Cardiol., vol. 26), pp. 995-1006.
Black et al., “Inhibition of In Vivo Myocardial Ischemia and Eperfusion Injury by a Synthetic Manganese-Based Superoxide Dismutase Mimetic”, 1994, (J. Pharmacol. Exp. Therapeut., vol. 270) pp. 1208-1215.
Venturini et al., “Manganese Based Superoxide Dismutase Mimic Protects Feline Myocardium fro Necrosis after Ischemia and Reperfusion”, In Biology of Nitric Oxide, 199
Brethauer Kerry
Forster Denis
Henke Susan
Ornberg Richard
Riley Dennis
Isabella David J
Pharmacia Corporation
Sonnenschein Nath & Rosenthal LLP
LandOfFree
Biomaterials modified with superoxide dismutase mimics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomaterials modified with superoxide dismutase mimics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomaterials modified with superoxide dismutase mimics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4031556